Glibenclamide for the Treatment of Acute CNS Injury

Pharmaceuticals - Switzerland
doi 10.3390/ph6101287
Full Text
Abstract

Available in full text

Date
Authors
Publisher

MDPI AG

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy